{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:23:25Z","timestamp":1784247805992,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Cholera and Enteric Diseases"},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.vaccine.2016.02.018","type":"journal-article","created":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T22:40:56Z","timestamp":1455403256000},"page":"1839-1846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Development of a cost-effective vaccine candidate with outer membrane vesicles of a tolA-disrupted Shigella boydii strain"],"prefix":"10.1016","volume":"34","author":[{"given":"Soma","family":"Mitra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritam","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Mitobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemanta","family":"Koley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.02.018_bib0005","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2471\/BLT.07.050054","article-title":"Estimating child mortality due to diarrhoea in developing countries","volume":"86","author":"Boschi-Pinto","year":"2008","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and etiology of diarrhoeal disease in infants and young children in developing countries (GEMS study): a prospective case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0015","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrmicro1662","article-title":"Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road","volume":"5","author":"Levine","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00970.x","article-title":"Immunology of gut mucosal vaccines","volume":"239","author":"Pasetti","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0025","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jac\/dkg080","article-title":"Growing antimicrobial resistance of Shigella isolates","volume":"51","author":"Ashkenazi","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0030","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1574-695X.2012.01004.x","article-title":"Outer membrane vesicles of Shigella boydii type 4 induce passive immunity in neonatal mice","volume":"66","author":"Mitra","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0035","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.vaccine.2013.05.001","article-title":"Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis","volume":"31","author":"Mitra","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trivac.2015.07.001","article-title":"Immunomodulatory role of outer membrane vesicles of Shigella in mice model","volume":"4","author":"Mitra","year":"2015","journal-title":"Trials Vaccinol"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.micro.091208.073413","article-title":"Biological functions and biogenesis of secreted bacterial outer membrane vesicles","volume":"64","author":"Kulp","year":"2010","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0050","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1128\/JB.180.18.4872-4878.1998","article-title":"Escherichia coli tol\u2013pal mutants form outer membrane vesicles","volume":"180","author":"Bernadac","year":"1998","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0055","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1365-2958.1991.tb01873.x","article-title":"The tol gene products and the import of macromolecules into E. coli","volume":"5","author":"Webster","year":"1991","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0060","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.resmic.2004.04.007","article-title":"Improved methods for producing outer membrane vesicles in Gram-negative bacteria","volume":"155","author":"Henry","year":"2004","journal-title":"Res Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0065","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1099\/mic.0.021576-0","article-title":"Deletion of tolA in Salmonella Typhimurium generates an attenuated strain with vaccine potential","volume":"155","author":"Paterson","year":"2009","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0378-1119(95)00193-A","article-title":"Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant","volume":"158","author":"Cherepanov","year":"1995","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0075","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1073\/pnas.120163297","article-title":"One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products","volume":"97","author":"Datsenko","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.gene.2009.02.015","article-title":"Application of lambda Red recombination system to Vibrio cholerae genetics: simple methods for inactivation and modification of chromosomal genes","volume":"438","author":"Yamamoto","year":"2009","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2958.2005.04938.x","article-title":"Release of the type I secreted alpha-haemolysin via outer membrane vesicles from Escherichia coli","volume":"59","author":"Balsalobre","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/168167a0","article-title":"A colorimetric method for determination of sugars","volume":"4265","author":"Dubois","year":"1951","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0095","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/ac60111a017","article-title":"Colorimetric method for determination of sugars and related substances","volume":"28","author":"DuBois","year":"1956","journal-title":"Anal Chem"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0100","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0110","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1128\/IAI.63.5.1947-1954.1995","article-title":"Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection","volume":"63","author":"van de Verg","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0115","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1128\/IAI.61.6.2390-2395.1993","article-title":"Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models","volume":"61","author":"Orr","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0120","doi-asserted-by":"crossref","first-page":"12589","DOI":"10.1074\/jbc.M111.335554","article-title":"Outer membrane protein A (OmpA) of Shigella flexneri 2a links innate and adaptive immunity in a TLR2-dependent manner and involvement of IL-12 and nitric oxide","volume":"287","author":"Pore","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0125","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1016\/j.vaccine.2013.05.100","article-title":"Outer membrane protein A (OmpA) from Shigella flexneri 2a: a promising subunit vaccine candidate","volume":"31","author":"Pore","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1615\/CritRevImmunol.v31.i1.70","article-title":"Role of CD3\u025b-mediated signaling in T-cell development and function","volume":"31","author":"Dave","year":"2011","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0167-5699(90)90085-N","article-title":"Role of the CD28 receptor in T-cell activation","volume":"11","author":"June","year":"1990","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0140","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1016\/S0264-410X(99)00046-8","article-title":"Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice","volume":"17","author":"Dalseg","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/IAI.67.1.113-119.1999","article-title":"Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice","volume":"67","author":"Saunders","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0150","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2958.1992.tb01523.x","article-title":"The excC gene of Escherichia coli K-12 required for cell envelope integrity encodes the peptidoglycan-associated lipoprotein (PAL)","volume":"6","author":"Lazzaroni","year":"1992","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0155","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1046\/j.1365-2958.2001.02673.x","article-title":"The TolQ\u2013TolR proteins energize TolA and share homologies with the flagellar motor proteins MotA-MotB","volume":"42","author":"Cascales","year":"2001","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0160","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-2958.2002.02895.x","article-title":"The Tol\/Pal system function requires an interaction between the C-terminal domain of TolA and the N-terminal domain of TolB","volume":"44","author":"Walburger","year":"2002","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0165","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1084\/jem.185.12.2089","article-title":"T cell stimulation in vivo by lipopolysaccharide (LPS)","volume":"185","author":"Tough","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0170","series-title":"Bacteria-cytokine interactions in health and disease","author":"Henderson","year":"1998"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0175","first-page":"223","article-title":"Th1\/Th2 balance: the hypothesis, its limitations, and implications for health and disease","volume":"8","author":"Kidd","year":"2003","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0180","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1128\/IAI.00714-12","article-title":"Stressor-induced increase in microbicidal activity of splenic macrophages is dependent upon peroxynitrite production","volume":"80","author":"Allen","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0185","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/intimm\/5.11.1383","article-title":"Induction of IFN-gamma in macrophages by lipopolysaccharide","volume":"5","author":"Fultz","year":"1993","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0190","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1189\/jlb.0406253","article-title":"Effects of LPS-mediated bystander activation in the innate immune system","volume":"80","author":"Yadav","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0195","first-page":"1709","article-title":"Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in SCID mice","volume":"59","author":"Bancroft","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0200","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.4049\/jimmunol.175.6.3463","article-title":"Directing transition from innate to acquired immunity: defining a role for IL-6","volume":"175","author":"Jones","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","article-title":"Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease","volume":"32","author":"Iyer","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0210","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1128\/IAI.00047-11","article-title":"Interleukin-10 immunity against prokaryotic and eukaryotic intracellular pathogens","volume":"79","author":"Cyktor","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0215","doi-asserted-by":"crossref","first-page":"e109107","DOI":"10.1371\/journal.pone.0109107","article-title":"Outer membrane protein A (OmpA) of Shigella flexneri 2a induces TLR2-mediated activation of B cells: involvement of protein tyrosine kinase, ERK and NF-\u03baB","volume":"9","author":"Bhowmick","year":"2014","journal-title":"PLoS ONE"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2016.02.018_bib0220","doi-asserted-by":"crossref","first-page":"iii37","DOI":"10.1136\/ard.2006.058446","article-title":"Role of nitric oxide in the regulation of T cell functions","volume":"65","author":"Niedbala","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0225","doi-asserted-by":"crossref","first-page":"e35616","DOI":"10.1371\/journal.pone.0035616","article-title":"High yield production process for Shigella outer membrane particles","volume":"7","author":"Berlanda Scorza","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.02.018_bib0230","doi-asserted-by":"crossref","first-page":"24922","DOI":"10.1074\/jbc.M114.566570","article-title":"Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutants","volume":"289","author":"Rossi","year":"2014","journal-title":"J Biol Chem"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T11:10:32Z","timestamp":1748776232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16001602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":45,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0264410X16001602"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a cost-effective vaccine candidate with outer membrane vesicles of a tolA-disrupted Shigella boydii strain","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}